Details for Patent: 5,731,000

✉ Email this page to a colleague

Summary for Patent: 5,731,000

Scope and claims summary:

Title:	Stabilized pharmaceutical composition containing bupropion
Abstract:	This application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80% of its initial bupropion potency after one year.
Inventor(s):	Ruff; Michael David (Greenville, NC), Kalidindi; Sanyasi Raju (Edison, NJ), Sutton, Jr.; Joel Elmore (Greenville, NC)
Assignee:	Glaxo Wellcome Inc. (Rtp, NC)
Application Number:	08/586,916
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 5,731,000

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,731,000

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9315856	Jul 30, 1993

PCT Information
PCT Filed	July 29, 1994	PCT Application Number:	PCT/GB94/01642
PCT Publication Date:	February 09, 1995	PCT Publication Number:	WO95/03791

International Family Members for US Patent 5,731,000

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	232383	⤷ Subscribe
Australia	698883	⤷ Subscribe
Australia	7235294	⤷ Subscribe
Canada	2168364	⤷ Subscribe
Germany	69432121	⤷ Subscribe
Denmark	0711154	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.